FDA 483 - Arifulla Khan MD - June 11, 2014

Arifulla Khan, M.D., a clinical investigator in Bellevue, WA, was cited for significant deficiencies in conducting clinical trials. The inspection revealed failures to adhere to investigational plans, including issues with contradictory subject eligibility documentation and improper management of investigational product non-compliance. Additionally, the firm failed to obtain proper informed consent and maintain accurate case histories, leading to critical data discrepancies.